Drug
Azd5213 Pregabalin
Azd5213 Pregabalin: highest development phase Phase 2, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD5213 + pregabalin NCT01928381 | Phase 2 | Diabetic Neuropathy, Painful; Diabetic Neuropathies |
Latest
No recent events.
Follow Azd5213 Pregabalin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.